Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
Open Access
- 4 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 18 (1), 1-18
- https://doi.org/10.1186/s12967-020-02498-3
Abstract
Distal cholangiocarcinoma is an aggressive malignancy with a dismal prognosis. Diagnostic and prognostic biomarkers for distal cholangiocarcinoma are lacking. The aim of the present study was to identify differentially expressed proteins between distal cholangiocarcinoma and normal bile duct samples. A workflow utilizing discovery mass spectrometry and verification by parallel reaction monitoring was used to analyze surgically resected formalin-fixed, paraffin-embedded samples from distal cholangiocarcinoma patients and normal bile duct samples. Bioinformatic analysis was used for functional annotation and pathway analysis. Immunohistochemistry was performed to validate the expression of thrombospondin-2 and investigate its association with survival. In the discovery study, a total of 3057 proteins were identified. Eighty-seven proteins were found to be differentially expressed (q < 0.05 and fold change ≥ 2 or ≤ 0.5); 31 proteins were upregulated and 56 were downregulated in the distal cholangiocarcinoma samples compared to controls. Bioinformatic analysis revealed an abundance of differentially expressed proteins associated with the tumor reactive stroma. Parallel reaction monitoring verified 28 proteins as upregulated and 18 as downregulated in distal cholangiocarcinoma samples compared to controls. Immunohistochemical validation revealed thrombospondin-2 to be upregulated in distal cholangiocarcinoma epithelial and stromal compartments. In paired lymph node metastases samples, thrombospondin-2 expression was significantly lower; however, stromal thrombospondin-2 expression was still frequent (72%). Stromal thrombospondin-2 was an independent predictor of poor disease-free survival (HR 3.95, 95% CI 1.09–14.3; P = 0.037). Several proteins without prior association with distal cholangiocarcinoma biology were identified and verified as differentially expressed between distal cholangiocarcinoma and normal bile duct samples. These proteins can be further evaluated to elucidate their biomarker potential and role in distal cholangiocarcinoma carcinogenesis. Stromal thrombospondin-2 is a potential prognostic marker in distal cholangiocarcinoma.Funding Information
- This research work was supported by government grant for clinical research (http://www.skane.se/fou/alf).
- Cancerfonden
- Erik and Angelica Sparres research foundation
This publication has 105 references indexed in Scilit:
- A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of CholangiocarcinomaJournal of Gastrointestinal Surgery, 2013
- Platform-independent and Label-free Quantitation of Proteomic Data Using MS1 Extracted Ion Chromatograms in SkylineMolecular & Cellular Proteomics, 2012
- Global quantification of mammalian gene expression controlNature, 2011
- Identification of Cellular Targets in Human Intrahepatic Cholangiocarcinoma Using Laser Microdissection and Accurate Mass and Time Tag ProteomicsMolecular & Cellular Proteomics, 2010
- Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycansThe FEBS Journal, 2010
- Proteomic Analysis of Differentially Expressed Proteins in Peripheral CholangiocarcinomaCancer Microenvironment, 2010
- Evaluation of Archival Time on Shotgun Proteomics of Formalin-Fixed and Paraffin-Embedded TissuesJournal of Proteome Research, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Differential Membrane Proteomics Using 18O-Labeling To Identify Biomarkers for CholangiocarcinomaJournal of Proteome Research, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008